We are live on ! Find out more
KA

KLCM Advisors Portfolio holdings

AUM $1.19B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
-3.95%
1 Year Est. Return
+34.45%
3 Year Est. Return
+97.42%
5 Year Est. Return
+107.96%
10 Year Est. Return
+263.06%
AUM
$466M
AUM Growth
+$13.6M
Cap. Flow
+$33.4M
Cap. Flow %
7.17%
Top 10 Hldgs %
46.05%
Holding
122
New
11
Increased
41
Reduced
30
Closed
3

Top Buys

Rank Stock Value
1
FLS icon
Flowserve
FLS
+$7.49M
2
T icon
AT&T
T
+$7.16M
3
THS
Treehouse Foods
THS
+$6.74M
4
ALSN icon
Allison Transmission
ALSN
+$4.87M
5
GTES icon
Gates Industrial Corporation Ltd.
GTES
+$4.17M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$9.99M
2
OGN icon
Organon & Co
OGN
+$796K
3
ORCL icon
Oracle
ORCL
+$539K
4
CTRA
Coterra Energy
CTRA
+$447K
5
BA icon
Boeing
BA
+$363K

Sector Composition

Rank Sector Weight
1 Industrials 17.02%
2 Technology 16.84%
3 Healthcare 15.7%
4 Financials 14.98%
5 Communication Services 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
76
Mastercard
MA
$502B
$409K 0.09%
1,175
+500
+74% +$182K
TGT icon
77
Target
TGT
$65.6B
$380K 0.08%
1,661
– –
CL icon
78
Colgate-Palmolive
CL
$73.1B
$378K 0.08%
5,003
– –
LNT icon
79
Alliant Energy
LNT
$18.3B
$356K 0.08%
6,366
– –
COST icon
80
Costco
COST
$422B
$343K 0.07%
764
+70
+10% +$30.8K
ANSS
81
DELISTED
Ansys
ANSS
$338K 0.07%
993
– –
WMB icon
82
Williams Companies
WMB
$87.5B
$328K 0.07%
+12,648
New +$318K
BMO icon
83
Bank of Montreal
BMO
$126B
$325K 0.07%
3,262
– –
K
84
DELISTED
Kellanova
K
$324K 0.07%
5,397
+514
+11% +$30.8K
MET icon
85
MetLife
MET
$61.9B
$322K 0.07%
5,218
+305
+6% +$18.4K
ACN icon
86
Accenture
ACN
$102B
$316K 0.07%
988
– –
BP icon
87
BP
BP
$116B
$310K 0.07%
11,339
– –
SLB icon
88
SLB Ltd
SLB
$73.6B
$295K 0.06%
9,954
+100
+1% +$2.87K
LOW icon
89
Lowe's Companies
LOW
$117B
$292K 0.06%
1,439
+101
+8% +$20.1K
SBUX icon
90
Starbucks
SBUX
$120B
$284K 0.06%
2,577
-500
-16% -$58.5K
ROK icon
91
Rockwell Automation
ROK
$53.4B
$273K 0.06%
927
– –
AMAT icon
92
Applied Materials
AMAT
$403B
$270K 0.06%
2,100
-280
-12% -$38K
NVDA icon
93
NVIDIA
NVDA
$4.86T
$265K 0.06%
+12,800
New +$266K
F icon
94
Ford
F
$58.5B
$259K 0.06%
18,282
-400
-2% -$5.44K
ESNT icon
95
Essent Group
ESNT
$6.08B
$250K 0.05%
5,678
-4,418
-44% -$200K
RTX icon
96
RTX Corp
RTX
$290B
$236K 0.05%
2,747
-149
-5% -$12.7K
PACW
97
DELISTED
PacWest Bancorp
PACW
$234K 0.05%
+5,161
New +$214K
VLO icon
98
Valero Energy
VLO
$90.1B
$229K 0.05%
3,250
+500
+18% +$33.3K
UNH icon
99
UnitedHealth
UNH
$376B
$226K 0.05%
578
– –
HUN icon
100
Huntsman Corp
HUN
$1.71B
$225K 0.05%
+7,615
New +$201K
1 2 3
4
5

Similar funds

PAMJ
Parvus Asset Management Jersey St. Helier, Jersey $1.18B AUM 53.98% 1-Year Est. Return
CCS
Concentric Capital Strategies Stamford, Connecticut $1.19B AUM 44.7% 1-Year Est. Return
CTC
Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return
NCMU
NAYA Capital Management (UK) London, United Kingdom $1.18B AUM 13.14% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
MMFA
Main Management Fund Advisors San Francisco, California $1.19B AUM 26.24% 1-Year Est. Return
OGC
Oak Grove Capital North Hampton, New Hampshire $1.18B AUM 84.79% 1-Year Est. Return
SCM
Sone Capital Management New York $1.19B AUM 14% 1-Year Est. Return

KLCM Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, KLCM Advisors held 122 positions worth $466M, up 3% from $452M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

KLCM Advisors deployed $33.4M of net new capital in Q3 2021, opening 11 new positions and adding to 41 existing holdings. Its largest new stake was Flowserve: 191,320 shares worth $6.63M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $9.99M trimmed.

  • KLCM Advisors's largest Q3 2021 buy was Flowserve: 191,320 shares worth $6.63M.
  • KLCM Advisors added most to AT&T in Q3 2021, an estimated $7.16M increase.
  • KLCM Advisors's biggest Q3 2021 reduction was Pfizer, cutting an estimated $9.99M.
  • KLCM Advisors fully exited Organon & Co in Q3 2021, selling an estimated $796K.
  • KLCM Advisors's ten largest holdings make up 46% of its $466M portfolio in Q3 2021.
  • KLCM Advisors opened 11 new positions and closed 3 in Q3 2021.
  • KLCM Advisors's portfolio value rose 3% quarter-over-quarter to $466M.

Based on KLCM Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.